Ajax-Loading

Astellas Pharma Inc. - Total Long Term Liabilities

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Total-Long-Term-Liabilities" stands at 746.10 Billion Japanese Yens as of 06/30/2025.

As of the end of Astellas Pharma Inc.'s first quarter, the item "Total Long Term Liabilities" stands at 746.10 Billion JPY. This represents a decrease of -2.43 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.88 percent compared to the value the year prior.
The 1 year change in percent is 8.88.
The 3 year change in percent is 268.90.
The 5 year change in percent is 147.32.
The 10 year change in percent is 1,257.00.

The Serie's long term average value is 223.25 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 234.20 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2014, to it's latest available value, on 06/30/2025, is +1,597.85%.
The Serie's change in percent from it's maximum value, on 09/30/2024, to it's latest available value, on 06/30/2025, is -11.08%.

Total Long Term Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Total Long Term Liabilities905,699,262,464.00
LogoJohnson & Johnson - Total Long Term Liabilities486,508,953,600.00
LogoAbbVie Inc - Total Long Term Liabilities399,570,305,024.00
LogoRoche Holding AG - Total Long Term Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Total Long Term Liabilities280,205,508,085.11